Literature DB >> 6150140

Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin.

A M Lever, A D Webster, D Brown, H C Thomas.   

Abstract

Acute non-A, non-B hepatitis developed in twelve patients with primary hypogammaglobulinaemia during treatment with intravenous gammaglobulin prepared by Cohn fractionation of pooled plasma. The illness was clinically and histologically identical to the short-incubation non-A, non-B, hepatitis observed in haemophilic patients receiving factor VIII concentrates. Most of the patients were symptomless, but 10 months after onset ten of the twelve still had abnormal liver function. The occurrence of non-A, non-B hepatitis in agammaglobulinaemics indicates that humoral mechanisms are not essential for production of hepatocyte necrosis in this infection. This outbreak emphasises the need for a screening test to identify the agent in blood products, and shows that Cohn fractionation of plasma does not always inactivate the agent. Furthermore, the finding that the virus can be transmitted in IgG concentrates suggests either that the general population has a very low level of antibodies to the putative virus or that such antibodies are not virus-neutralising.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150140     DOI: 10.1016/s0140-6736(84)91506-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  28 in total

Review 1.  Viral contamination of monoclonal antibody preparations: potential problems and possible solutions.

Authors:  C Harbour; G Woodhouse
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

Review 2.  Newer uses of intravenous immunoglobulins as anti-infective agents.

Authors:  J E Pennington
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 3.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

4.  Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-01-15       Impact factor: 8.262

Review 5.  Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

Review 6.  X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.

Authors:  C I Smith; C M Bäckesjö; A Berglöf; L J Brandén; T Islam; P T Mattsson; A J Mohamed; S Müller; B Nore; M Vihinen
Journal:  Springer Semin Immunopathol       Date:  1998

Review 7.  Non-A, non-B hepatitis: dead ends or new horizons?

Authors:  S A Iwarson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-17

Review 8.  Intravenous immunoglobulin in neurological disease: a specialist review.

Authors:  C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 9.  Intravenous immune globulin in primary immunodeficiency.

Authors:  M Haeney
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 10.  The nontreatment of childhood idiopathic thrombocytopenic purpura.

Authors:  G R Buchanan
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.